Paras, Monica .
HRN: 00-32-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/27/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/27/2023
02/02/2023
IVT
500mg
Q8
Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes